TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ALX Oncology to Present at Upcoming Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Alx Oncology Holdings Inc.
ALX Oncology to Present at Upcoming Investor Conferences

ALX Oncology will participate in two healthcare conferences in November and December 2025, presenting their ongoing clinical-stage cancer therapies, including lead candidate evorpacept and new pipeline candidate ALX2004.

Insights
EEM   negative

Higher expense ratio (0.72%), less diversified with concentrated holdings, lower dividend yield (2.1%), and lower historical returns


ALXO   positive

Company is presenting at major healthcare conferences, highlighting ongoing clinical trials and pipeline progress in cancer therapies, indicating active research and development